Flavin-containing Monooxygenase (FMO3) Links the Gut and Fibrosis in Systemic Sclerosis

被引：0

作者：

Verma, Priyanka ^{[1
]}

Yalavarthi, Bharath ^{[1
]}

Ho, Karen ^{[2
]}

Muhammad, Lutfiyya ^{[3
]}

Kim, Seokjo ^{[4
]}

Gudjonsson, Johann ^{[1
]}

Schugar, Rebecca C. ^{[5
]}

Brown, Mark ^{[6
]}

Li, Xinmin ^{[6
]}

Hazen, Stanley L. ^{[7
]}

Bhattacharyya, Swati ^{[1
]}

Varga, John ^{[1
]}

机构：

[1] Univ Michigan, Ann Arbor, MI 48109 USA

[2] Northwestern Univ, Chicago, IL 60611 USA

[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[4] 4SCM Lifesci Co Ltd, Incheon, South Korea

[5] Stanford Univ, Stanford, CA 94305 USA

[6] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA

[7] Stanford Univ, Dept Med, Div Endocrinol, Stanford, CA 94305 USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0953

引用

页码：1874 / 1876

页数：3

共 50 条

[31] Three novel single nucleotide polymorphisms of the flavin-containing monooxygenase 3 (FMO3) gene in a Japanese population
Yamazaki, Hiroshi
Shimizu, Makiko
DRUG METABOLISM REVIEWS, 2006, 38 : 38 - 38
[32] Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population
Yamazaki, Hiroshi
Fujita, Haruka
Gunji, Takaaki
Zhang, Jun
Kamataki, Tetsuya
Cashman, John R.
Shimizu, Makiko
MOLECULAR GENETICS AND METABOLISM, 2007, 90 (01) : 58 - 63
[33] In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles
Cashman, JR
Xiong, Y
Lin, J
Verhagen, H
van Poppel, G
van Bladeren, PJ
Larsen-Su, S
Williams, DE
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (06) : 1047 - 1055
[34] Busulphan Metabolism Via Flavin-Containing Monooxygenase 3 (FMO3) Can Explain Several Interactions with Other Drugs
El Serafi, Ibrahim
Abedi-Valugerdi, Manuchehr
Naughton, Sean
Saghafian, Maryam
Mattsson, Jonas
Moshfegh, Ali
Terelius, Ylva
Potacova, Zuzana
Hassan, Moustapha
BLOOD, 2014, 124 (21)
[35] Mutations in the flavin-containing monooxygenase form 3 (FMO3) gene cause trimethylaminuria, fish odour syndrome.
Akerman, BR
Chow, L
Forrest, S
Youil, R
Cashman, J
Treacy, EP
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A53 - A53
[36] Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms:: linkage and effects on in vivo and in vitro FMO activities
Park, CS
Kang, JH
Chung, WG
Yi, HG
Pie, JE
Park, DK
Hines, RN
McCarver, DG
Cha, YN
PHARMACOGENETICS, 2002, 12 (01): : 77 - 80
[37] FLAVIN-CONTAINING MONOOXYGENASE (FMO)-DEPENDENT METABOLISM OF METHIONINE AND EVIDENCE FOR FMO3 BEING THE MAJOR FMO INVOLVED IN METHIONINE SULFOXIDATION IN RABBIT LIVER AND KIDNEY MICROSOMES
DUESCHER, RJ
LAWTON, MP
PHILPOT, RM
ELFARRA, AA
JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (26) : 17525 - 17530
[38] Tolerance to Acetaminophen Hepatotoxicity in the Mouse Model of Autoprotection Is Associated with Induction of Flavin-Containing Monooxygenase-3 (FMO3) in Hepatocytes
Rudraiah, Swetha
Rohrer, Philip R.
Gurevich, Igor
Goedken, Michael J.
Rasmussen, Theodore
Hines, Ronald N.
Manautou, Jose E.
TOXICOLOGICAL SCIENCES, 2014, 141 (01) : 263 - 277
[39] A series of simple detection systems for genetic variants of flavin-containing monooxygenase 3 (FMO3) with impaired function in Japanese subjects
Shimizu, Makiko
Mizugaki, Ami
Koibuchi, Natsumi
Sango, Haruna
Uenuma, Yumi
Yamazaki, Hiroshi
DRUG METABOLISM AND PHARMACOKINETICS, 2021, 41
[40] Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway (vol 12, e0187294, 2017)
El-Serafi, I
Terelius, Y.
Abedi-Valugerdi, M.
Naughton, S.
Saghafian, M.
Moshfegh, A.
PLOS ONE, 2017, 12 (12):

← 1 2 3 4 5 →